Target intelligence / Profile preview

Chloride channel protein (family member) (ClC (for CLC family members, e.g., ClC-1, ClC-2, etc.))

Target
ClC (for CLC family members, e.g., ClC-1, ClC-2, etc.)
Molecular classification
Ion channel, Voltage-gated ion channel (CLC subfamily), Ligand-gated ion channel (GABA(A), glycine receptors), ATP-regulated/ABC transporter-like ion channels (CFTR), Intracellular anion channels (CLIC family), Transporter (some CLCs function as antiporters rather than channels)
01

Overview

The **chloride channel protein family members**, collectively known as **chloride channels**, comprise several molecular families responsible for mediating the movement of chloride ions across cellular membranes. The main families include: #### Major Families: | Family | Example Members | Function | |--------|----------------|----------| | **CLC Family (Voltage-Gated)** | ClC‑0 through ClC‑7; ClC-Ka/Kb | Regulate electrical excitability; acidify organelles; kidney salt handling | | **CLIC Family (“Intracellular” Channels)** | CLIC1–6 | Regulate membrane potential and transepithelial transport | | **CFTR (“ABC Transporter” Channel)** | CFTR/ABCC7 | Epithelial fluid secretion; mutated in cystic fibrosis | | **Ligand-Gated Channels (“Neurotransmitter Receptors”)** | GABA(A), glycine receptors | Mediate synaptic inhibition | These proteins share a common function—selective passage of Cl- ions—but differ widely in structure and regulatory mechanisms. They play critical roles throughout physiology including neuronal signaling, muscle contraction relaxation cycles, epithelial fluid balance especially within kidneys/lungs/glands, cell volume regulation under osmotic stress conditions, and acidification processes within endosomes/lysosomes. Mutations or dysregulation cause diverse human diseases ranging from neuromuscular disorders to kidney tubulopathies to life-threatening lung disease such as cystic fibrosis. Because “chloride channel protein family member” is not a unique entity but rather refers generically to any one among dozens of related but distinct molecules with different tissue distributions/functions/disease associations/drug sensitivities,[4] precise identification at the gene/protein level is required when considering therapeutic targeting or clinical interpretation.[10]

Other names
Chloride channelCLC chloride channelCLIC chloride intracellular channelCFTR (for cystic fibrosis transmembrane conductance regulator)GABA(A) receptor chloride channelGlycine receptor chloride channel
02

Mechanism of action

Depends on subtype; general mechanisms include: - Channel blockers/inhibitors reduce chloride conductance. - Channel openers/potentiators increase activity. For ligand-gated types: * Positive allosteric modulators enhance gating by neurotransmitters. For CFTR: * Potentiators/correctors restore function in cystic fibrosis. For voltage-gated types: * Modulators alter gating kinetics or voltage sensitivity.[4]

03

Biological functions

Regulation of membrane potential and cellular excitabilityTransepithelial transport of ions in kidney and other tissuesCell volume regulationAcidification of intracellular organelles/endosomes/lysosomesSynaptic inhibition via ligand-gated channels in the nervous system
04

Disease associations

Myotonia congenita ("ClC‑1", skeletal muscle disorder)Dent's disease ("ClC‑5", renal tubular disorder)Bartter syndrome ("ClC-Ka/Kb", renal salt-wasting disorders)Cystic fibrosis ("CFTR")Other roles include epilepsy, neurodegenerative diseases, and possibly cancer depending on the specific member.
05

Safety considerations

Targeting these proteins can cause off-target effects due to their widespread physiological roles.Inhibition can lead to muscle dysfunction, neurological side effects, electrolyte imbalance/kidney dysfunction depending on tissue distribution.Some are essential for basic cell homeostasis.[3][5]
06

Interacting drugs

Varies by subtype; examples include:

4 more in the full profile.

07

Biomarkers

Specific mutations in genes encoding certain members are used as biomarkers for inherited diseases:Mutations in CLCN1 for myotonia congenita,Mutations in CFTR for cystic fibrosis,Mutations in CLCNKB for Bartter syndrome type III.[8][9]No universal biomarker exists for the entire family.

Beyond the preview

Go deeper on Chloride channel protein (family member) (ClC (for CLC family members, e.g., ClC-1, ClC-2, etc.)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chloride channel protein (family member) (ClC (for CLC family members, e.g., ClC-1, ClC-2, etc.)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call